My Web Dashboard





SEO News: ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept in Rheumatoid Arthritis (FinanzNachrichten)

SEATTLE and GENEVA, Dec. 20 /PRNewswire-FirstCall/ -- ZymoGenetics, ( Nachrichten ) Inc. and Serono ( Nachrichten / Aktienkurs ) (NYSE: SRA; virt-x: SEO) today announced the start of a Phase 2 clinical trial in which atacicept therapy will be evaluated in patients with rheumatoid arthritis (RA). The randomized, double-blind, multi-center study will investigate the efficacy of atacicept in ...

read more...

Related News